Mitoxantrone modulates a glycosaminoglycan-spike complex to inhibit SARS-CoV-2 infection
Qi Zhang(Northeast Agricultural University), Yihong Ye(National Institute of Diabetes and Digestive and Kidney Diseases), Wei Zheng(Liaoning Cancer Hospital & Institute), Vivian Cao-Dao(National Institutes of Health), Peter Radvák(Slovak University of Technology in Bratislava), Hang Xie(Nanjing University of Chinese Medicine), Miao Xu(National Center for Advancing Translational Sciences), Yue Xu(China Pharmaceutical University), Juhyung Lee(National Institute of Diabetes and Digestive and Kidney Diseases), Catherine Z. Chen(National Institutes of Health)
Cited by 0
Related Papers
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
|Cell|2020|802
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2015|348
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
|Emerging Microbes & Infections|2014|242
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
|ACS Pharmacology & Translational Science|2020|225